SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruit

One quarter after announcing a disappointing book-to-bill ratio, CRO Parexel has now renewed its strategic partnership with GlaxoSmithKline and seen its book-to-bill ratio jump to its highest level since 2012.

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision medicine initiative before a crowd of industry, government and academic scientists and congressmen.

Icon, PPD expand further into Ireland with more jobs, warehousing space

While Icon is adding 200 new jobs at a new innovation center in Ireland, PPD is looking to double its packaging warehousing capabilities and quadruple its distribution services on the island.

News in brief

BioClinica, Theorem join ACRO as new members

The Association of Clinical Research Organizations (ACRO) is bringing in BioClinica as a regular member and Theorem Clinical Research as an associate member.

Valeant eyes up personalised meds market with $300m Provenge bid

Valeant is set to buy Dendreon’s prostate cancer drug Provenge as an economic way to enter the personalised oncology market.

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

AstraZeneca has partnered to use the CRISPR genome editing technique across its discovery programmes in a move that puts it on a collision course with French Biotech, Cellectis.

Google picks Biogen Idec MS project for research partnership

Google and Biogen Idec are teaming up to crack multiple sclerosis, the latest crossover between pharma and the wearables world.

HCV drugs Sovaldi and Elysio boost Q1 sales for AmeriSourceBergen

New hepatitis C drugs produced by Gilead, Janssen and AbbVie contributed to a first quarter spike in revenue for AmeriSourceBergen’s Pharmaceutical Distribution business.

Spotlight

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway
Competition

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway

Did you know that throughout the nineteenth century, vaccination left a scar known as “the mark of...

Charles River considers re-opening preclinical site in Mass.

Charles River considers re-opening preclinical site in Massachusetts

CRO Charles River Laboratories (CRL) may re-open a preclinical site in Shrewsbury, MA, if demand for the...

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

Parexel’s improved book-to-bill ratio is a reassuring sign for the company and the CRO industry as a whole,...

Crown expands Precos site to build caucasian cancer expertise

Crown expands Precos site to build caucasian cancer expertise

Crown Biosciences has announced plans to double capacity at a site operated by its Precos division.

Oil slump good for API makers, until a major supplier turns off the tap says industry group

Oil slump good for API makers, until a major supplier turns off the tap says industry group

Falling oil prices are good news for firms that make pharmaceutical ingredients according to a European chemical...

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

Japan was involved in fewer drug industry-sponsored multi-regional clinical trials (MRCT) in 2014 than any year since...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...